Hrusch Cara L, Tjota Melissa Y, Sperling Anne I
Committee on Immunology, University of Chicago, Chicago, IL, USA.
Curr Allergy Asthma Rep. 2015 Jan;15(1):494. doi: 10.1007/s11882-014-0494-9.
Promoting tolerance to inhaled antigens is an active area of study with the potential to benefit the millions of Americans currently suffering from respiratory allergies and asthma. Interestingly, not all individuals with atopy are symptomatic, arguing that sensitization alone does not lead to an allergic clinical phenotype. Respiratory dendritic cells (rDCs), classically associated with inducing inflammatory responses, can actively promote tolerance. Tolerance can be broken when inflammatory stimuli, including viral infections and other environmental exposures, inhibit rDC-mediated tolerance by allowing innocuous antigen to be presented to initiate type-2 immunity. Importantly, rDCs are composed of multiple subsets, each with a unique response to an inhaled antigen that can lead to either tolerance or inflammation. In this review, we will discuss how rDC subsets actively maintain tolerance or, alternatively, break tolerance in response to environmental cues.
促进对吸入性抗原的耐受性是一个活跃的研究领域,有望使数百万目前患有呼吸道过敏和哮喘的美国人受益。有趣的是,并非所有特应性个体都有症状,这表明仅致敏并不导致过敏性临床表型。呼吸道树突状细胞(rDCs)通常与诱导炎症反应相关,但也能积极促进耐受性。当包括病毒感染和其他环境暴露在内的炎症刺激通过允许无害抗原呈递以启动2型免疫来抑制rDC介导 的耐受性时,耐受性就会被打破。重要的是,rDCs由多个亚群组成,每个亚群对吸入性抗原都有独特的反应,这可能导致耐受性或炎症。在这篇综述中,我们将讨论rDC亚群如何根据环境线索积极维持耐受性,或者相反,打破耐受性。